Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole L Berger

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Cancer Drug Targets|December 8, 2004
The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapyCarole L Berger, Richard Edelson
Leukemia & Lymphoma|December 25, 2003
Current concepts of the immunobiology and immunotherapy of cutaneous T cell lymphoma: insights gained through cross-talk between the clinic and the benchCarole L Berger, Richard L Edelson
Journal of Immune Based Therapies and Vaccines|July 21, 2005
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingMaria Salskov-Iversen, Carole L Berger, Richard L Edelson
Immunological Investigations|November 11, 2008
Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loadingXiaoyan Shen, Carole L Berger, Robert Tigelaar, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 20, 2002
Transimmunization, a novel approach for tumor immunotherapyCarole L Berger, Douglas Hanlon, Daniel Kanada, et al.
Journal of Immune Based Therapies and Vaccines|February 13, 2007
Improved generation of anti-tumor immunity by antigen dose limitationJoshua D Shofner, Juan G Vasquez, Carole L Berger, et al.
The International Journal of Biochemistry & Cell Biology|May 16, 2006
Langerhans cells: mediators of immunity and toleranceCarole L Berger, Juan Gabriel Vasquez, Joshua Shofner, et al.
Blood|October 30, 2004
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cellsCarole L Berger, Robert Tigelaar, Justine Cohen, et al.
Leukemia & Lymphoma|September 13, 2006
Transimmunization for cutaneous T cell lymphoma: a Phase I studyMichael Girardi, Carole L Berger, Lynn D Wilson, et al.
The Journal of Investigative Dermatology|January 19, 2006
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong, Adam J Wilson, Heather M Gibson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Cancer Drug Targets|December 8, 2004
The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapyCarole L Berger, Richard Edelson
Leukemia & Lymphoma|December 25, 2003
Current concepts of the immunobiology and immunotherapy of cutaneous T cell lymphoma: insights gained through cross-talk between the clinic and the benchCarole L Berger, Richard L Edelson
Journal of Immune Based Therapies and Vaccines|July 21, 2005
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingMaria Salskov-Iversen, Carole L Berger, Richard L Edelson
Immunological Investigations|November 11, 2008
Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loadingXiaoyan Shen, Carole L Berger, Robert Tigelaar, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 20, 2002
Transimmunization, a novel approach for tumor immunotherapyCarole L Berger, Douglas Hanlon, Daniel Kanada, et al.
Journal of Immune Based Therapies and Vaccines|February 13, 2007
Improved generation of anti-tumor immunity by antigen dose limitationJoshua D Shofner, Juan G Vasquez, Carole L Berger, et al.
The International Journal of Biochemistry & Cell Biology|May 16, 2006
Langerhans cells: mediators of immunity and toleranceCarole L Berger, Juan Gabriel Vasquez, Joshua Shofner, et al.
Blood|October 30, 2004
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cellsCarole L Berger, Robert Tigelaar, Justine Cohen, et al.
Leukemia & Lymphoma|September 13, 2006
Transimmunization for cutaneous T cell lymphoma: a Phase I studyMichael Girardi, Carole L Berger, Lynn D Wilson, et al.
The Journal of Investigative Dermatology|January 19, 2006
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong, Adam J Wilson, Heather M Gibson, et al.
Pageof 2